Statement | SD | D | N | A | SA | Rating Count |
---|---|---|---|---|---|---|
n (%) | n (%) | n (%) | n (%) | n (%) | ||
The risk of stroke versus the risk of bleeding is clearly articulated to patients when commencing anticoagulation for stroke prevention in AF | 3 (6) | 9 (17) | 14 (26) | 24 (44) | 4 (7) | 54 |
I am unsure whether to advocate for thromboprophylaxis or not when involved in team decisions | 7 (13) | 22 (41) | 14 (26) | 10 (19) | 1 (2) | 54 |
It’s difficult to decide where the benefits of thromboprophylaxis outweigh the risks of hemorrhage | 3 (7) | 27 (50) | 10 (19) | 14 (26) | 0 (0) | 54 |
I feel I do not know enough about the risk and benefits of different anticoagulants | 5 (9) | 30 (57) | 4 (8) | 12 (23) | 2 (4) | 53 |
I take time to understand my patients views on the risks and benefits of anticoagulation | 0 (0) | 7 (13) | 10 (19) | 31 (58) | 6 (11) | 54 |
Generally, my patients are well informed about the risks and benefits of anticoagulation at time of commencement | 3 (6) | 8 (15) | 11 (20) | 28 (52) | 4 (7) | 54 |
My patients receive comprehensive education about anticoagulation prior to discharge | 2 (4) | 5 (9) | 10 (19) | 26 (48) | 11 (20) | 54 |
I use the CHADS2 or CHA2DS2-VASc scores with patients to help risk stratify stroke risk in clinical practice | 6 (12) | 12 (23) | 15 (29) | 13 (25) | 6 (12) | 52 |
I use the HAS-BLED score with patients to help risk stratify bleeding risk in clinical practice | 11 (22) | 13 (26) | 16 (31) | 9 (18) | 2 (4) | 51 |
I use shared decision making with patients to explain the risks and benefits of anticoagulation for stroke prevention in AF | 5 (9) | 7 (13) | 14 (26) | 23 (43) | 5 (9) | 54 |